First Tracks Biotherapeutics, Inc. (TRAX)

NASDAQ: TRAX · Real-Time Price · USD

45.50

+1.62 (3.69%)

At close: Aug 19, 2026, 4:00 PM EDT

45.71

+0.21 (0.46%)

After-hours: Aug 19, 2026, 7:30 PM EDT

TRAX Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-160.3	-166.09	-163.71	-106.15
Depreciation & Amortization	1.55	2.42	2.4	2.38
Loss (Gain) From Sale of Investments	-1.33	-4.73	-10.31	-10.52
Stock-Based Compensation	36.72	32.3	26.83	18.39
Change in Accounts Payable	11.12	-5.31	17.81	8.39
Change in Other Net Operating Assets	-11.51	-1.52	1.18	-5.49
Operating Cash Flow	-123.76	-142.93	-125.81	-93
Operating Cash Flow Growth	-	-	-	-
Capital Expenditures	-0.06	-0.09	-0.36	-0.81
Investment in Securities	211.8	228.12	95.76	145.56
Investing Cash Flow	211.74	228.03	95.4	144.75
Issuance of Common Stock	316.58	30.01	117.52	-
Other Financing Activities	-280.83	-	-	-87.09
Financing Cash Flow	35.74	30.01	117.52	-87.09
Net Cash Flow	123.72	115.12	87.12	-35.34
Free Cash Flow	-123.82	-143.01	-126.16	-93.81
Free Cash Flow Growth	-	-	-	-
Levered Free Cash Flow	-	-82.76	-63.42	-
Unlevered Free Cash Flow	-	-82.76	-63.42	-
Change in Working Capital	-0.39	-6.83	18.99	2.9